Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PDE4B inhibitors(Phosphodiesterase 4B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 11 Jun 2024 | |
Multiple Sclerosis | Preclinical | US | 11 Jun 2024 | |
Neuronal Ceroid-Lipofuscinoses | Preclinical | US | 11 Jun 2024 | |
Parkinson Disease | Preclinical | US | 11 Jun 2024 | |
Substance-Related Disorders | Preclinical | US | 02 Apr 2024 |